Showing results (301-310 of 663) with videos related to
Sort By:
Pageof 67
IEEE Transactions on Neural Networks and Learning Systems|July 2, 2026
Negation of Basic Belief Assignment in Multisource Information Fusion on Dempster-Shafer Theory With Applications in Pattern ClassificationXingyu Liu, Linlin Fan, Xuekai Wei, et al.International Orthopaedics|July 21, 2026
Patient-Specific Instrumentation Improves Technical Execution Accuracy After Artificial Intelligence-Assisted Preoperative Planning in Medial Unicompartmental Knee ArthroplastyDehua Liu, Yaheng Zhao, Zirun Gao, et al.European Journal of Pharmacology|August 7, 2026
Alloimperatorin enhances chemosensitivity by modulating the c-MYC/NBS1 axis to induce sustained DNA damageShuting Han, Jiaru Wang, Jiao Xue, et al.Microbial Pathogenesis|December 23, 2015
Comparative transcriptome analysis of Brucella melitensis in an acidic environment: Identification of the two-component response regulator involved in the acid resistance and virulence of BrucellaQianhong Liu, Xingyu Liu, Feng Yan, et al.Frontiers in Computational Neuroscience|December 17, 2020
DNNBrain: A Unifying Toolbox for Mapping Deep Neural Networks and BrainsXiayu Chen, Ming Zhou, Zhengxin Gong, et al.International Journal of Molecular Sciences|February 15, 2022
The Effect of RADA16-I and CDNF on Neurogenesis and Neuroprotection in Brain Ischemia-Reperfusion InjuryXingyu Liu, Haiyuan Ren, Ai Peng, et al.Molecular Cancer|November 19, 2023
ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinomaTushuai Li, Longjiang Xu, Zhe Wei, et al.Journal of Hepatocellular Carcinoma|August 28, 2023
Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A ReviewXiangze Wang, Minghui Zhao, Chensheng Zhang, et al.Sensors (Basel, Switzerland)|September 28, 2023
Research on Simultaneous Measurement of Magnetic Field and Temperature Based on Petaloid Photonic Crystal Fiber SensorLili Yan, Qichao Wang, Bin Yin, et al.Frontiers in Oncology|December 13, 2021
Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II StudyQiyi Zhang, Xingyu Liu, Shumei Wei, et al.Pageof 67